Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN)

Historical Holders from Q1 2019 to Q4 2023

Type / Class
Equity / Common Stock, no par value
Symbol
CYCN on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2023 Q4 0 $0 -$2,000 0
2023 Q3 552 $2,000 $3.62 1
2023 Q2 552 $2,000 -$17,810,737 $3.62 1
2023 Q1 20,630,088 $8,949,493 +$16,936 $0.43 30
2022 Q4 20,827,653 $13,665,576 -$347,030 $0.66 36
2022 Q3 21,236,761 $18,262,273 +$225,673 $0.86 29
2022 Q2 20,901,901 $11,469,174 -$2,261,052 $0.55 32
2022 Q1 23,051,679 $25,583,454 -$790,969 $1.11 42
2021 Q4 23,664,601 $40,699,713 -$4,573,203 $1.72 48
2021 Q3 24,690,641 $75,797,940 +$263,245 $3.07 52
2021 Q2 24,615,826 $96,000,462 +$9,555,790 $3.90 60
2021 Q1 22,395,892 $62,484,018 +$1,379,472 $2.79 67
2020 Q4 21,864,958 $66,903,716 -$6,229,664 $3.06 69
2020 Q3 22,941,416 $139,523,457 +$32,049,269 $6.08 65
2020 Q2 17,688,979 $104,540,887 -$4,008,711 $5.91 67
2020 Q1 18,528,720 $49,097,876 +$8,211,551 $2.65 67
2019 Q4 15,376,074 $41,819,093 -$70,347,297 $2.72 68
2019 Q3 19,547,298 $236,934,655 +$1,931,372 $12.12 84
2019 Q2 19,469,585 $222,922,553 +$213,114,445 $11.45 93
2019 Q1 855,056 $12,666,000 +$12,665,000 $15.13 3